Showing results (21-30 of 83) with videos related to
Sort By:
Pageof 9
Journal of Hepatology|July 16, 2011
Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosisGian Maria Prati, Alessio Aghemo, Maria Grazia Rumi, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 6, 2016
Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus InfectionAlessio Aghemo, Elisabetta Degasperi, Stella De Nicola, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 22, 2024
Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methodsMaria Paola Anolli, Sara Uceda Renteria, Elisabetta Degasperi, et al.Hepatology (Baltimore, Md.)|May 24, 2012
Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis CAlessio Aghemo, Gian Maria Prati, Maria Grazia Rumi, et al.Biomed Research International|August 13, 2013
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patientsAlessio Aghemo, Elisabetta Degasperi, Maria Grazia Rumi, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2018
12 weeks ombitasvir/paritaprevir-ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosisElisabetta Degasperi, Alessio Aghemo, Stefania Paolucci, et al.JHEP Reports : Innovation in Hepatology|March 7, 2025
Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDVMaria Paola Anolli, Sara Uceda Renteria, Elisabetta Degasperi, et al.Viral Immunology|July 12, 2021
The CCR5 and CXCR3 Pathways in Hepatitis C Virus Liver Transplanted Recipients Treated by a Direct Antiviral Agent Regimen: Informative Kinetics ProfilesGiuseppe Colucci, Federica Invernizzi, Sara Uceda Renteria, et al.Journal of Hepatology|March 19, 2013
Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infectionBarbara Oliviero, Dalila Mele, Elisabetta Degasperi, et al.Journal of Hepatology|March 17, 2023
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In CirrhoticsMaria Paola Anolli, Elisabetta Degasperi, Lena Allweiss, et al.Pageof 9